002916:SZSEShennan Circuit Co., Ltd. Class A Analysis
Data as of 2026-03-15 - not real-time
CN¥250.23
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Shennan Circuits is trading at CNY 250.23, comfortably above its 20‑day SMA of 259.48 but still under the 50‑day SMA of 244.69, indicating a short‑term bullish bias despite a recent pullback. The RSI sits at 47.7, near the neutral zone, while the MACD histogram is negative (-2.88) and the signal line is bearish, suggesting momentum may be waning. Volume trends are decreasing, which could foreshadow a consolidation phase as the price approaches the resistance level of 295.66. Fundamentally, revenue surged 41.9% YoY and ROE stands at a healthy 20.6%, but the stock commands a steep PE of 51 versus the industry average of 33.7, and the DCF fair‑value estimate of 143.30 is far below the market price, flagging significant overvaluation. The dividend yield is modest at 0.46% with a payout ratio of 23.5%, supporting sustainability but offering limited income appeal. Market sentiment is in “greed” territory (Fear‑Greed Index 72.9), yet the 30‑day volatility is high at 64.6%**, and the beta is low (0.24), indicating the stock is volatile but not strongly correlated with broader market moves.
Given the strong growth backdrop and solid profitability, the medium‑term outlook remains positive, but the current price premium and weakening technical momentum counsel caution. Investors should monitor volume, MACD behavior, and any near‑term catalyst that could either validate the upside potential (~10% above current price) or trigger a correction toward the support level of 221.75. The combination of high valuation, robust fundamentals, and moderate dividend sustainability suggests a nuanced position: hold for now, with a bias toward buying on dips if the technicals stabilize.
Given the strong growth backdrop and solid profitability, the medium‑term outlook remains positive, but the current price premium and weakening technical momentum counsel caution. Investors should monitor volume, MACD behavior, and any near‑term catalyst that could either validate the upside potential (~10% above current price) or trigger a correction toward the support level of 221.75. The combination of high valuation, robust fundamentals, and moderate dividend sustainability suggests a nuanced position: hold for now, with a bias toward buying on dips if the technicals stabilize.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and decreasing volume
- Price nearing resistance at 295.66
- Overvaluation relative to DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth of 41.9% YoY
- Analyst consensus of strong buy and upside potential of ~10%
- Solid ROE of 20.6% and sustainable dividend payout
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Fundamental strengths in profitability and cash generation
- Persistent valuation premium versus peers
- Moderate dividend yield with low payout ratio supporting sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth41.90%
Profit Margin13.85%
P/E Ratio51.1
ROE20.60%
ROA8.00%
Debt/Equity20.71
P/B Ratio9.7
Op. Cash FlowCN¥3.8B
Free Cash FlowCN¥-833735040
Industry P/E33.7
Technical Analysis
TrendBullish
RSI47.7
SupportCN¥221.75
ResistanceCN¥295.66
MA 20CN¥259.48
MA 50CN¥244.69
MA 200CN¥183.01
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueCN¥143.30
Target PriceCN¥276.24
Upside/Downside10.40%
GradeOvervalued
TypeGrowth
Dividend Yield0.46%
Risk Assessment
Beta0.24
Volatility64.62%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.